Companies / CME vs NDAQ
CME vs NDAQ: CME Group and Nasdaq
CME Group (CME) reported $6.5B in revenue against a 62.5% net margin, while Nasdaq (NDAQ) reported $8.3B at a 21.6% net margin, most recently.
| Metric | CME | NDAQ |
|---|---|---|
| Revenue | $6.5B | $8.3B |
| Net Income | $4.1B | $1.8B |
| Gross Margin | — | 63.5% |
| Operating Margin | 64.9% | 28.2% |
| EPS (Diluted) | $11.16 | $3.09 |
| Free Cash Flow | $4.2B | $2.0B |
| Total Debt | $3.4B | $9.0B |
| P/E Ratio | 24.5× | 31.4× |
| P/B Ratio | n/m | 4.5× |
| Stock Price | $307.24 | $107.37 |
Free: last 5 years
| Fiscal year | FY2008 🔒 | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CME Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $4.7B | $5.0B | $5.6B | $6.1B | $6.5B |
| NDAQ Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $5.9B | $6.2B | $6.1B | $7.4B | $8.3B |